RIPK2 and colonic neoplasm: NOD2 (or RIPK2) deficiency results in increased susceptibility to tumor formation in AOM/DSS mouse model of colon cancer. Absence of NOD2 (or RIPK2) promotes pro‐inflammatory microenvironment in the intestines leading to enhanced epithelial dysplasia following chemically induced injury.